© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Some of the most influential medicines and agricultural chemicals trace their origins to the often-overlooked world of heterocyclic compounds. Pyrimidines entered the scene in the late 1800s, carved out of curiosity for the molecular puzzle behind nucleic acids—the building blocks of life. Piperazine, recognized for its peculiar two-nitrogen, six-membered structure, sparked excitement among chemists by bringing versatility to both biological and industrial chemistry. Although these discoveries predate modern drug design, they set the table for everything from penicillin to next-generation cancer therapies. If you look at the medicine cabinet or even the pesticide shelf, you’ll find these humble rings tucked behind familiar product names. Their persistence over so many decades points to how foundational chemistry continues to quietly shape our daily lives.
You won’t find a standard shape, scent, or function uniting pyrimidine and piperazine hybrids. These molecules often look nondescript, yet their impact runs deep, especially in pharmaceuticals and crop science. Take pyrimidine: tweak a carbon here and a nitrogen there, and suddenly you’re holding the core of a life-saving antiviral or a cornerstone of the herbicide that protects food crops. Piperazine rings introduce flexibility, bringing new opportunities for receptor binding and water solubility—a real bonus for designing drugs that the body actually absorbs. Medicinal chemists have built hundreds of names on the scaffolds of pyrimidine and piperazine, each altered slightly to coax a new property for a targeted job. Sometimes, the difference between a safe medicine and a toxic one is just a subtle shift in structure. A single new arrangement of atoms can breathe life into a patent, feeding innovation in an era when medical breakthroughs no longer come easy.
These heterocycles play tricks on the senses. Pyrimidines can resemble powders, crystals, or even viscous tars, largely hydrophobic and stable under reasonable conditions. Piperazines, meanwhile, often show up as white crystalline solids, but they can easily slip into solution with the right concentration of acid or water. The real fascination comes from their dual personality. Many pyrimidine derivatives resist breaking down under heat, which supports industrial-scale reactions. Piperazine rings bring more flair—capable of toggling between protonated and unprotonated forms, granting chemists a flexible handle for building more complex structures or driving bioactivity. Together, these rings serve as a Swiss Army knife for researchers, especially when complicated multi-step syntheses rely on their predictable behavior.
Expansion in this field comes from patient, methodical work. Synthetic routes have evolved from basic amination and cyclization strategies to modern, high-yield processes enabled by microwave irradiation, transition metal catalysis, and flow chemistry. Old-school methods multiply chemicals in large flasks, but many labs now harness robotics for optimizing reaction times and improving yields. Each generation of chemists builds on the last, learning from both spectacular breakthroughs and humbling failures. Peering into the literature, you’ll see pyrimidine and piperazine rings spliced, fused, or tweaked with electron-donating or -withdrawing groups, supported by years of accumulated tricks. New synthetic techniques don’t just push academic frontiers; they break down the price barriers that once kept lifesaving drugs out of reach for patients in lower-income countries.
Greater utility comes from the nearly endless reactivity of these compounds. Pyrimidine rings, for one, offer multiple sites for nucleophilic or electrophilic attack; chemists regularly swap, add, or clip substituents for greater drug-likeness or stability. Piperazine groups open the door to ring-opening, N-alkylation, acylation, and more complex multistep syntheses. Through robust chemistry such as palladium-catalyzed cross-coupling, researchers install diverse groups, fine-tuning the pharmacological activity and disposition in the body. The beauty of this flexibility is clear in drug discovery pipelines, where rapid analog development speeds up the search for new therapies. Time and again, the broad scope of chemical maneuverability translates to solutions targeted to some of the most persistent health and agricultural crises worldwide.
Whoever coined the phrase "naming is half the battle" probably never dealt with chemical synonyms. Trade names spring up for marketing, systematic names for publication, and trivial names for convenience in the lab. Pyrimidine derivatives might carry simple labels as “cytosine,” “uracil,” or more tangled names formed by IUPAC rules. Piperazine blends into countless product names, from antihelminthics to psychotropics, each with its own legacy and cautionary tale. A single compound might go by a dozen monikers, making consistency an ongoing challenge for researchers trying to avoid duplicate experiments or patent landmines. Yet this diversity reflects the robust ecosystem supporting these molecules worldwide.
Ask anyone in a chemistry lab and they’ll have a story about proper handling—sometimes learned the hard way. Pyrimidine and piperazine compounds can present risks ranging from mild skin irritation to eye damage and organ toxicity, especially during chronic exposure or large-scale production. Institutions enforce robust handling protocols, requiring gloves, goggles, and fume hoods. Safety isn’t just about checking boxes; it’s about protecting lives and maintaining trust. The research community looks to global standards and updates regularly as new health effects come to light. Mistakes can ripple beyond the immediate lab, so a culture of vigilance takes root, reducing accidents and shaping policy in real time.
Life as we know it would look different without these heterocycles. Pyrimidines form the backbone of genetic code, driving the replication and repair mechanisms that keep organisms functioning. In agriculture, substituted pyrimidines and piperazines fight everything from fungal blight to invasive pests, helping keep global food supplies steady. In medicine, they anchor treatments for diseases as diverse as cancer, depression, malaria, and viral infections—each application made possible by decades of sweat and experimentation in the lab. The world has watched as COVID-19 fuels a spike in antiviral drug research, many of which build on the core chemical logic of these ancient rings. Sometimes, the smallest molecular tweaks lead to the next generation of treatments, reinforcing the notion that chemistry matters far beyond the page of a textbook.
If there’s one thing experience teaches, it’s that chemistry thrives on collaboration—and fierce competition. Global research teams chase new derivatives, functionalized rings and clever delivery systems, working to outpace bugs, resistance, and evolving patient needs. Pyrimidine and piperazine-based scaffolds fill high-throughput screening libraries from Shanghai to Boston, all hoping to stumble upon that rare hit that might stop cancer growth, silence a virus, or neutralize a resistant weed. Computational chemistry now sits alongside bench experiments, narrowing huge lists of candidates to the most promising molecules based on structure-activity relationships. Funding agencies and venture capitalists keep a close eye on progress, betting on the next blockbuster that could leap from petri dish to clinical trial. The pipeline remains full, though breakthroughs never come easy. Still, optimism endures because the utility of these rings keeps defeating obstacles, proof that incremental advances add up over time.
Every new compound faces a gauntlet of toxicity tests, both in vitro and in animal models, to prevent repeat tragedies of past chemical accidents. Pyrimidine derivatives, found in DNA and RNA, usually earn a head start in safety assessments but new synthetic analogs demand fresh scrutiny for off-target effects. Piperazine-based medicines, long-used for treating worms and certain psychiatric conditions, have a history well-mapped by toxicologists for both therapeutic and accidental overdoses. New derivatives prompt careful checks for carcinogenicity, mutagenicity, and environmental impact. Regulatory agencies require transparency throughout, and old assumptions dissolved rapidly when unexpected side effects surfaced. Researchers invest in better models—both computational and biological—recognizing that failing early often saves more than just money.
Every year brings reports of drug-resistant microbes, aggressive cancers, and new plant diseases—a modern reminder that resting on past success courts disaster. Firms and universities push to harness artificial intelligence and green chemistry for faster, cleaner syntheses. The hunt continues for novel bioisosteres that improve safety or shorten manufacturing. Environmental impact now plays a bigger role, pushing the industry toward degradable, less toxic options without sacrificing performance. Future prospects hang on balancing speed, cost, and sustainability. One hard-won lesson from decades of research: even familiar molecules can surprise. The best discoveries sometimes come from those willing to look again at the old to find something new.
Few molecules impact our lives the way pyrimidine and piperazine structures have. Look at hospital pharmacies and drug cabinets, and these two show up everywhere, quietly enabling some of the most critical therapies available. Pyrimidines give us the backbone of many cancer drugs, antiviral treatments, and antibiotics. Take 5-fluorouracil, for instance—a well-known chemotherapy staple for treating solid tumors. On the infectious disease front, some of the most trusted HIV drugs build on these same scaffolds to attack viral replication at its source. Piperazine rings contribute to the versatility and potency of antipsychotics like quetiapine and antimalarials such as chloroquine. Over decades, drug designers have kept reaching for these frameworks because they reliably provide activity and stability in living systems.
Farming depends on robust, safe pest management. Here, pyrimidine and piperazine compounds play double duty. Modern fungicides and insecticides often feature these rings, since their shapes interact precisely with pests’ enzymes and nerve systems. Some of the latest crop protection options are based on pyrimidine derivatives that target and shut down pathogens without building up heavy residues. Farmers benefit from less crop loss and consumers gain confidence in what winds up on kitchen tables. There’s clear evidence that new piperazine-based products are helping curb resistance trends that older pesticides couldn’t manage, so the demand keeps rising.
Doctors need more than great drugs—they also need to see what’s going on inside the body. Here, pyrimidine and piperazine systems show up again. Many radiotracers and fluorescent dyes for imaging blood flow, organ function, or tumor spread borrow from these chemistries. Their structures let scientists fine-tune how long the tracer stays in the body and what tissues it highlights. In nuclear medicine, pyrimidine-based nucleotides tag specific genetic sequences, helping pinpoint mutations or cancer signatures. By making diagnostics more targeted and more sensitive, these compounds help doctors catch problems earlier.
Outside health care, pyrimidine and piperazine hybrids bring value to electronics, batteries, and even plastics. Research teams have leveraged their nitrogen-rich rings to build polymers that conduct electricity, hold charges, or resist chemical wear. These materials wind up in displays, solar panels, and specialty coatings. The ease of modifying these rings gives engineers flexibility in tuning their properties; a small tweak in the lab can mean better shelf life or improved performance in the field. Companies pushing greener manufacturing also lean on these compound types, since they’re easier to recycle or break down safely compared to some older chemical families.
Access to life-saving medicines still faces hurdles. Some essential drugs based on these rings stay out of reach in lower-income regions, not for lack of chemistry but due to cost and distribution gaps. Research funding often overlooks the basic science behind these compounds, even though their impact spans health, agriculture, and technology. One way to help: encourage partnerships between universities, industry, and governments to share new discoveries and accelerate approvals. We’ve already seen what these compounds can accomplish—wider collaboration could magnify their benefits across fields that touch millions of people every day.
Pyrimidine forms the backbone of life’s playbook as a key building block in DNA and RNA. The scaffold itself, made up of nitrogen atoms at the right spots in a six-membered ring, changes the way it bonds with other molecules. Pyrimidine stands out for its moderate alkalinity, which helps in forming hydrogen bonds that play a huge role in pairing nucleic acids. This moderate basicity lets scientists tweak its structure for medicinal use—to build the backbone of antiviral, anticancer, and anti-inflammatory drugs.
Pyrimidine’s nitrogen atoms make it more electron-rich than benzene, but it resists chemical attack in certain areas, which guides which substitutions stick during synthesis. This “directing” effect has shaped decades of drug development. By changing out chemical groups at select positions on the ring, teams can control how compounds interact with the body. As a medicinal chemist, I’ve seen firsthand how fine-tuning the ring’s substitutions increases water solubility or blocks a molecule from being chewed up too fast by the liver. This balance between stability in the body and bioactivity matters for real-world medicines.
Swing the focus to piperazine, and you see a molecule prized for its flexibility. In a simple sense, it’s a six-membered saturated ring with two nitrogen atoms sitting opposite each other. That setup gives piperazine strong basicity—a trait chemists lean on for proton exchange and salt formation. It dissolves well in water and acts as a bridge to attach drug-like groups or to help drugs get across cell membranes.
Experience in the lab has taught me the value of piperazine’s basic nitrogen atoms. They open the door for its transformation through alkylation and acylation, giving rise to compounds that can either block or boost signals in the brain. Antipsychotic and antihistaminic medicines often bear this ring, precisely because it shapes how a molecule fits into biological targets. The ease of modifying piperazine’s ring—plus its compatibility with many functional groups—encourages creativity in drug design.
When chemists merge pyrimidine and piperazine, the result often surpasses the sum of its parts. These hybrid molecules bring out the strongest features of each: the electronic versatility of pyrimidine, mixed with the flexibility and basic nature of piperazine. This duo crops up in drugs that target infections, cancer, and neurological conditions.
One example from recent work involves tweaking a pyrimidine-bearing piperazine to boost its activity against resistant bacterial strains. By shaping the molecule to resist enzymatic attack, its stability in acidic environments shot up compared to simpler structures. Studies show that such combinations often increase the capacity to cross biological membranes, which means better absorption in the gut for oral medications.
The union isn’t just for drugs. Dye chemists call on these scaffolds for their strong binding to metals and their use in sensors, pushing forward environmental testing. Yet, this innovation raises challenges—resistance in microbes, toxicity in complex biological systems, and unpredictable metabolism. Addressing these challenges calls for a focus on selectivity, thorough toxicity testing, and green chemistry in manufacturing. Chemical innovation serves society best when it balances creative discovery with deep responsibility.
Plenty of people trust that products or chemicals found on store shelves won’t cause any problems. That’s a comforting thought, but it doesn’t always match reality. Even cleaning agents hiding under our sinks, let alone reagents in a school or industrial lab, often have warnings printed right on the label. And those aren’t just for show. At one point, I picked up a bottle of pool chlorine without gloves, and my hands felt slick. That “slick” feeling meant the skin’s natural oils were breaking down—a wake-up call that even common items can bite back.
Damage from chemicals isn’t a rare horror story. According to OSHA, thousands of workers suffer injuries every year because of careless handling or improper protection. Some compounds irritate skin or lungs; others cause deeper, sneakier problems after weeks or months of exposure. Ammonia, for example, doesn’t mess around—breathing in its vapor stings the nose and eyes, and strong concentrations burn. Acids, bases, and solvents ask for respect, whether they’re used in a garage project or research experiment.
Mixing substances ramps up the stakes. Acids and bleach, for instance, release toxic chlorine gas if they touch. I once watched a janitor at a school cough uncontrollably from a cleaning mix-up—proof that “common sense” isn’t a given when people juggle multiple bottles, especially in a rush. This kind of mistake happens more often than most would like to admit.
A little planning saves more than a little heartache. Wearing gloves, goggles, and a good lab coat works better than learning about symptoms after exposure. The CDC lists personal protective equipment as the most effective barrier between people and chemical hazards. In a world where shortcuts tempt everyone, the right gear acts like an insurance policy nobody brags about, but everybody misses once it’s gone.
Ventilation deserves as much attention as clothing. Chemical vapors don’t always carry a smell. Invisible hazards travel fast in closed spaces, turning a quick task into a trip to the doctor. Fume hoods and open windows make a critical difference, especially in cramped workshops and school labs.
Clear rules and instructions don’t mean much when skipped or skimmed. In my time helping train new lab staff, I saw many try to wing it, assuming past experience trumped written guidance. It’s tempting to fast-forward through safety sheets, but missing details invites accidents. Proper labeling, regular reviews, and honest discussions about near-misses help build habits that protect everyone.
Technology and research keep changing best practices, so nobody stays ahead just by relying on old habits. The National Institute for Occupational Safety and Health regularly updates safe handling lists. Staying curious—asking questions, requesting new data sheets, and paying attention to current recommendations—helps everyone stay healthy.
Not all jobs require the most hazardous tools. Swapping safer alternatives makes a real difference. Water-based cleaners do much of the heavy lifting without harsh chemicals in many scenarios. Industry leaders look for “green chemistry” that skips over corrosive or toxic materials when possible. Even small workplaces catch on, checking product info and rethinking what’s truly necessary.
Nobody has to be an expert chemist to stay out of the emergency room. Simple habits—reading labels, suiting up, checking airflow, and learning from others—put a gap between day-to-day work and real danger. Safety doesn’t slow down a project; it keeps people around long enough to enjoy its results.
Working with pyrimidine and piperazine-containing compounds means always thinking about stability. Over the years, any researcher who has returned to a bottle of these chemicals, only to find clumping, discoloration, or an off odor, knows that proper storage means fewer headaches. Chemical degradation feels like wasted effort and lost resources, especially with expensive or hard-to-source reagents. Preserving stability isn’t just about checking off safety boxes—it's about protecting research investments and pushing science forward without unnecessary repetition.
Both pyrimidine and piperazine rings show sensitivity to their environment. Exposure to air, moisture, or broad temperature swings often triggers hydrolysis, oxidation, or unwanted side reactions. Light, especially UV, can cause slow but steady breakdown, creating byproducts that reduce purity. Even a humidity spike in the room can result in water-loving compounds absorbing enough moisture to cake up or even react.
Residual solvents pose another challenge. Impurities—formic acid from handling, or traces of chlorides from glassware—kick off decomposition. Pyrimidine and piperazine derivatives aren’t just textbook molecules; they show real-life quirks that demand attention.
Reliable storage habits make a difference. Keeping these compounds in airtight, amber glass bottles limits light exposure and blocks oxygen or water vapor. I’ve learned the hard way that plastic containers sometimes let in air or leach out plasticizers, so glass stays as the gold standard for anything that matters.
Temperature control stands out next. A steady spot in a chemical refrigerator at 2–8°C prevents most breakdown routes. Going colder—into deep freezers—can help with known unstable derivatives, but pulling bottles in and out for repeated use causes condensation and cycles of temperature shock. If the chemistry bench doesn’t have a dedicated fridge, even a lockbox inside a larger cold room saves compounds from months of unpredictable swings.
Desiccants in secondary containers add another layer of moisture protection. Silica gel or molecular sieves work well, but swapping them out regularly matters. Once the color strip shows full hydration, it’s already too late for several water-sensitive compounds.
Labeling every batch with a receipt date, synthesis lot, and storage conditions gives future scientists a fighting chance when tracking down stability issues. A small chart tracking how many times the container gets opened also helps. Even with the best habits, oxygen sneaks in after fifteen or twenty openings, so for extremely valuable compounds, subdividing shipments into small vials slows down the march toward degradation.
Research teams benefit from easy-to-follow standard operating procedures. A one-page sheet by the chemical shelf makes a bigger impact than a forgotten manual on a hard drive. Sharing photos of stable versus degraded material helps new lab members spot issues before mistakes set back a whole week of effort.
Chemical suppliers can help too. Prefilled ampules with inert gas headspace, cold-chain delivery, or extra-dry packaging provide layers of insurance for high-value molecules. Discussing storage questions with technical support from suppliers has saved me from relying on guesswork and learning by trial and error.
Looking at the bigger picture, investing time in labeling and storage pays out in saved budgets, sharper research results, and fewer safety incidents. For pyrimidine and piperazine chemicals, thoughtful storage makes research smoother and keeps frustrations at bay.
In research labs, pharmaceuticals, agriculture—wherever chemicals show up—purity turns into a hot topic. I’ve worked with plenty of samples over the years, and a single slip-up leads to failed batches, wasted money, or even safety risks. Asking how to check a compound's purity isn’t just technical. You want to trust what’s in the vial, especially if it’s headed into a patient’s bloodstream or onto a food crop.
High Performance Liquid Chromatography (HPLC) jumps to mind as the workhorse. It separates the ingredients in a mix and shows exactly what’s in there, down to parts per million. In my lab days, every time someone asked, “Is this sample clean?” the HPLC would settle the question. HPLC not only tells you what you have, but in the hands of a good tech, it flags sneaky contaminants the naked eye would miss.
Gas Chromatography (GC) enters the picture for compounds that turn into gases when heated. Organic chemists swear by GC to catch impurities in solvents, active ingredients, or even street drugs. Where HPLC drives biologists, GC keeps the chemists honest.
Mass Spectrometry (MS) often links up with HPLC or GC, lifting the whole process into detective mode. Not only can MS sniff out impurities by size and charge, but pattern-matching tools help scientists figure out where those stray molecules came from. MS takes purity testing beyond “does it match the recipe?” and into “what are these unknowns and should we worry?”
Melting Point Analysis sometimes shows up in classroom labs, especially with simple organics. If a solid melts at the expected temperature, that’s a basic sign it’s pure. Any deviation hints at contamination. While this method isn’t enough on its own, it’s a fast first look before rolling out the expensive machines.
Titration gives old-school accuracy for some compounds. Monitoring color changes or voltage shifts, you get direct numbers about concentration—vital in pharmaceuticals and food industries. Not everything needs an expensive instrument, and titration proves simple techniques still matter.
Watching news stories about contaminated drugs or food recalls, I keep thinking back to hours in the lab, triple-checking results. I remember the nervousness before releasing a batch, because one missed impurity means putting people at risk. In 2018, a contaminated blood pressure medication led to worldwide recalls because of trace carcinogens—a single step missed in testing created a public health crisis. In these real cases, the cost of cutting corners or skipping a second round of HPLC ripples far beyond the lab.
Shortcuts feel tempting, especially in tight-budget settings or under pressure to speed up production. Automation and better data systems can help, pushing routine checks to machines trained to flag odd results. In-house training keeps technicians sharp and ready to catch tricky cases. Regulatory agencies, like the FDA or EMA, set strict protocols, but audits work best when the people in the lab care about details. Building a culture of double-checking and sharing data openly stops problems before they reach customers or patients.
No one test serves every purpose, so teams mix approaches. For a life-saving medicine, multiple rounds—HPLC, MS, and visual checks—feel justified. In high-volume agriculture, routine sampling and audits keep everything above board. My best advice: know your material, understand what’s likely to hide inside, and never skimp on the tools to check.
Getting purity right is about more than compliance. It’s about the trust placed in every bottle, tablet, or shipment leaving a facility. Reliable analytical methods, used thoughtfully, make sure that trust remains unbroken.
| Names | |
| Preferred IUPAC name | 1-(Pyrimidin-2-yl)piperazine |
| Other names |
Cyclic Pyrimidine-Piperazine Derivatives Pyrimidinylpiperazines Piperazinylpyrimidines Pyrimidine piperazine hybrids Pyrimidine-piperazine fused rings |
| Pronunciation | /pɪˈrɪm.ɪ.diːn ˌpaɪ.pəˈreɪ.zɪn kənˈteɪ.nɪŋ hɛt.əˈroʊ.saɪ.klɪk ˈkɒm.paʊndz/ |
| Identifiers | |
| 3D model (JSmol) | Sure. Here is the **JSmol 3D model string** (commonly the **SMILES** representation) for a generic **Pyrimidine/Piperazine-containing heterocyclic compound**: ``` c1cnc(N2CCNCC2)nc1 ``` This represents a pyrimidine ring attached to a piperazine moiety. |
| Beilstein Reference | Beilstein Reference: 23, IV, 347 |
| ChEBI | CHEBI:51168 |
| ChEMBL | CHEMBL3614443 |
| ChemSpider | 21088857 |
| DrugBank | DB12760 |
| ECHA InfoCard | **50-05-5** |
| EC Number | EC 1.14.13.39 |
| Gmelin Reference | Gmelin Reference: 79235 |
| KEGG | map01100 |
| MeSH | D010936 |
| PubChem CID | 1087 |
| RTECS number | UJ8750000 |
| UNII | 50SW7C8UO1 |
| UN number | 3276 |
| Properties | |
| Chemical formula | C8H10N4 |
| Molar mass | 218.28 g/mol |
| Appearance | White solid |
| Odor | amine-like |
| Density | 1.23 g/cm3 |
| Solubility in water | Insoluble in water |
| log P | 2.95 |
| Vapor pressure | 0.0 mmHg at 25°C |
| Acidity (pKa) | 4.23 |
| Basicity (pKb) | 3.1 |
| Refractive index (nD) | 1.578 |
| Dipole moment | 2.94 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 352.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -31.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -4747 kJ/mol |
| Pharmacology | |
| ATC code | N05CF |
| Hazards | |
| Main hazards | Main hazards: Harmful if swallowed, causes skin and eye irritation, may cause respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07, GHS08 |
| Signal word | Warning |
| Hazard statements | H302+H312+H332, H315, H319, H335 |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P308+P313, P332+P313, P337+P313, P362+P364, P501 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 0, Special: - |
| Flash point | 58°C |
| Lethal dose or concentration | LD50 oral rat > 5000 mg/kg |
| LD50 (median dose) | LD50 (median dose): >5000 mg/kg (rat, oral) |
| NIOSH | NIOSH: Not established |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Pyrimidine/Piperazine-Containing Heterocyclic Compounds: "Not specifically established |
| REL (Recommended) | REL (Recommended): 10 mg/m3 |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
4-Phenylpyrimidine Piperazine 2-Aminopyrimidine 1-(2-Pyrimidinyl)piperazine Imidazopyridine Pyridine Pyrazine Quinazoline Triazine |
